As Senior Vice President, Finance & Operations at Neurvati Neurosciences and GRIN Therapeutics, Elliott Ruiz oversees finance, operations, and information technology. With a foundation in healthcare finance and corporate strategy, Elliott brings extensive experience leading financial planning, capital structure design, and operational integration in complex, high-growth settings. His background has spanned investment banking at Truist Securities, healthcare corporate finance at KPMG, and corporate development, capital raising, and financial planning and analysis at specialty pharmaceutical companies like Alvogen and Imbrium Therapeutics. He earned his BA in economics from Cornell University and his MBA from the Darden School at the University of Virginia, and has completed executive leadership training at the Yale School of Management.